Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Alcohol Withdrawal Resident Rounds July 10, 2007 Maggie Gordon, R2 Alcohol Withdrawal Importance in surgery Definitions Pathophysiology Signs and symptoms Treatment Importance in Surgery Importance ~15% primary care and hospitalized patients have problem drinking 23% admitted general surgery patients meet “alcohol abuse” criteria Early detection and intervention are very effective complications mortality Importance Tolerance to anaesthesia, analgesia physiologic reserve stress response morbidity, mortality ICU, hospital stays bleeding infections Tachycardias, cardiac output Definitions At-risk drinking Men: > 16 drinks / week Women: > 10 drinks / week Alcohol Abuse (DSM IV) Maladaptive use with work / school / social / interpersonal / legal consequences At risk of withdrawal Alcohol Dependence (DSM IV) Maladaptive use with ≥ 3 of: At risk of withdrawal Tolerance Withdrawal Used in larger quantity than intended Desire to cut down or control use Time is spent obtaining, using, or recovering Social, occupational, or recreational tasks are sacrificed Use continues despite physical and psychological problems Pathophysiology Pathophysiology EtOH = CNS depressant serotonin → tolerance, craving Withdrawal GABA → arousal norepi Signs and Symptoms Signs and Symptoms Spectrum of Presentation Severity Timing Minor Withdrawal Symptoms CNS, sympathetic activity: Insomnia Mild anxiety Palpitations Tremors Diaphoresis Headache GI upset Anorexia Onset: 6 – 48 h post EtOH cessation Duration: 24 – 48 h Withdrawal Seizures Generalized, tonic-clonic Brief post-ictal period Single episode, usually 3% → status epilepticus Risk Factors Long Hx Chronic alcoholism Investigate further Onset: 2 – 48 h post EtOH cessation Alcoholic Hallucinosis Usually visual, specific hallucinations Occasionally auditory, tactile Onset: 12 – 24 h post EtOH cessation Duration: 24 – 48 h No “clouding of sensorium” Delirium Tremens Hallucinations Disorientation HR BP temperature Diaphoresis Agitation Autonomic instability Onset: 2 – 4 days post EtOH cessation Duration: 1 – 5 days Delirium Tremens cardiac output O2 consumption cerebral blood flow Hyperventilation → Respiratory alkalosis Risk factors Long binge Significant clouding of sensorium Delirium Tremens Risk Factors Sustained drinking Previous DTs > 30 y.o. Concurrent illness Delayed presentation to medical care / assessment Delirium Tremens 5% mortality Arrhythmias Complicating illness, e.g. pneumonia Risk factors for death age Pulmonary disease T > 40°C Liver disease Withdrawal Syndromes Description Onset (since last EtOH) Duration Comments Minor Withdrawal Insomnia Mild anxiety Palpitations Tremors Diaphoresis Headache GI upset Anorexia <6h x 24 – 48 h Consistent in each patient Seizures Generalized Tonic-clonic 2 – 48 h 3% of chronic alcoholics Alcoholic Hallucinosis Usually visual Occasionally auditory, tactile 12 – 24 h x 24 – 48 h No clouding of sensorium Delirium Tremens Hallucinations Disorientation HR BP temperature Agitation Diaphoresis 2–4d x1–5d 5% of patients w/ withdrawal Treatment Prevention Pre-op CAGE questionnaire Have you ever felt the need to Cut down on drinking? Have you ever felt Annoyed by criticism of your drinking? Have you ever had Guilty feelings about your drinking? Do you ever take a morning Eye opener (a drink first thing in the morning to steady your nerves or get rid of a hangover)? Prevention Consider pre-op Collateral from family LET’s Prevention Thiamine, folate, multivitamins Abstinence Detox and rehab Referrals Early prophylaxis, i.e., before symptoms appear History First EtOH use Hx of withdrawal syndromes, especially seizures Physical Exam Vitals Tremor Investigations Blood work CBC for Hgb, platelets LFT’s CT LP Investigations Rule out and treat Infection Trauma Metabolic derangements Drug overdose Liver failure GI bleeding Diagnosis of exclusion Keys to Therapy Substitute drug of abuse with long-acting medication with similar effects, then taper dose Keys to Therapy Reevaluate frequently Avoid complacency Alleviate symptoms Keys to Therapy Hydrate (dehydration ← diaphoresis, T, vomiting, HR) Correct electrolytes K ( K ← vomiting, aldosterone Δs) Mg ( Mg → DT risk) PO4 ( PO4 ← malnutrition) Therapy Wernicke’s encephalopathy, Korsakoff’s syndrome prophylaxis Thiamine 100 mg im / iv Folic acid 5 mg po / iv daily x 3 days Multivitamin 1 tablet po daily x indefinite Therapy Benzodiazepines Diazepam (Valium) 5 – 10 mg po / iv q 5-10 min Lorazepam (Ativan) 1 – 2 mg po / sl / iv q 5-10 min liver disease → t½ First dose when CIWA ≥ 8 Titrate until patient “calm, but alert”, i.e. to CIWA score < 16 May need “massive” doses CIWA Therapy Consider prophylaxis w/out titration Emergency surgery Patient unable to communicate Diazepam 2.5 – 10 mg po / iv q 6 h Lorazepam 0.5 – 2 mg po / iv q 6 h Refractory Seizures, DTs Phenobarbital 130 – 260 mg iv q 15 – 20 min Propofol 1 mg / kg iv push, intubate, then titrate to sedation Long-Term Therapy Evaluation Referral to long-term follow-up No evidence of effectiveness References NEJM UpToDate UpToDate Symptom-Oriented Therapy ICU patients Flunitrazepam, clonidine, halperidol Fixed-dose CIWA-triggered Withdrawal severity Worse Better Total dose Greater Lesser Days ventilated Greater Fewer Pneumonia Greater Fewer ICU stay Longer Shorter Symptom-Triggered Doses Detox program Oxazepam Fixed-dose CIWA-triggered Outcomes Similar Total dose Greater Lesser Treatment duration Greater Lesser For Discussion Indications for ICU Admission Age > 40 y.o. Cardiac disease Hemodynamic instability Marked acid-base disturbances Severe electrolyte disturbances Respiratory insufficiency Potentially serious infections GI pathology Persistent hyperthermia Rhabdomyolysis Renal insufficiency Previous DTs, seizures Need for high doses of sedatives, iv therapy UpToDate